A Yale-led study examines the potential environmental benefits of more carefully selecting patients for prostate biopsy in a way that can also spare low-yield and potentially harmful procedures. Yale ...

First Focal One ® procedure utilizing Cortechs.ai’s advanced MRI-imaging technology, OnQ Prostate, successfully performed at the University of California, San Francisco Prostate Cancer Center OnQ ...

MRI of the prostate, combined with a blood test, can help determine if a prostate lesion is clinically significant cancer, new research suggests An enlarged prostate or potential prostate cancer is a ...

An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following inconclusive or reassuring results from an MRI scan, new research has found. Findings ...

QUINCY — A new imaging procedure at Quincy Medical Group will allow for more precise detection of prostate cancer and lead to improved treatment for men. The prostate-specific membrane antigen or PSMA ...

A scan that makes prostate cancer cells “glow” could halve the number of men needing invasive biopsies, research suggests.

AI-assisted imaging improved prostate cancer diagnosis and biopsy decision-making in new research presented at EAU 2026.

An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following ...

Use of the Prostatype P-score to predict adverse pathology (AP) at radical prostatectomy (RP). This is an ASCO Meeting Abstract from the 2024 ASCO Genitourinary Cancers Symposium. This abstract does ...

– TULSA treatment demonstrates a meaningful and statistically significant improvement over robotic RP in the preservation of erectile function together with continence at 6 months – ...